Legal status · United States
Is Semaglutide with B12 legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Semaglutide with B12 is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
Semaglutide with B12 in the United States at a glance
| Classification | Not approved; research use only |
|---|---|
| Note | Compounded by 503A and 503B pharmacies on prescription. Semaglutide itself is approved; this fixed combination is not, and is not reviewed by FDA. |
| FDA approval status | Not an approved product. Compounded preparations are not FDA approved and are not reviewed for safety, effectiveness or quality, and FDA has stated concerns about unapproved GLP-1 products sold for weight loss. |
| Human studies cited | 2 of 4 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Semaglutide with B12 profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing Semaglutide with B12 is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What Semaglutide with B12 is
A compounded premix in which the B12 dose is decided by the semaglutide dose rather than by anyone's B12 level. Cyanocobalamin sits at 0.5 mg/mL across strengths while semaglutide is 1 or 5 mg/mL, so the same product delivers five times more B12 per milligram of semaglutide on one strength than on the other. No trial has tested the combination, and no trial supports the reason it is added.
Compounding pharmacies pair semaglutide with cyanocobalamin and the stated reasons are that B12 helps with the nausea and with the fatigue people report on a GLP-1. Neither claim has a trial behind it.
Mechanism: Semaglutide is a GLP-1 receptor agonist that slows gastric emptying and reduces appetite through central and peripheral GLP-1 signalling. Cyanocobalamin is a vitamin B12 form used to correct deficiency, and its physiological effects in a person who is not deficient are minimal.
Regulatory history: Not an approved product. Compounded preparations are not FDA approved and are not reviewed for safety, effectiveness or quality, and FDA has stated concerns about unapproved GLP-1 products sold for weight loss.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Semaglutide with B12 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Semaglutide with B12 in other countries
Frequently asked questions
Is Semaglutide with B12 legal in the United States?
No. Semaglutide with B12 is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile. Note: Compounded by 503A and 503B pharmacies on prescription. Semaglutide itself is approved; this fixed combination is not, and is not reviewed by FDA.
Can I buy Semaglutide with B12 in the United States?
No approved product exists to buy. In the United States Semaglutide with B12 is classified as "Not approved; research use only", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Compounded by 503A and 503B pharmacies on prescription. Semaglutide itself is approved; this fixed combination is not, and is not reviewed by FDA.
Is Semaglutide with B12 FDA approved?
No. FDA status: Not an approved product. Compounded preparations are not FDA approved and are not reviewed for safety, effectiveness or quality, and FDA has stated concerns about unapproved GLP-1 products sold for weight loss.. Current US classification: "Not approved; research use only". On the evidence, 2 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Semaglutide with B12 live on its compound profile.
Semaglutide with B12 profileThis page is general information about the regulatory status of Semaglutide with B12 in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.